Value Bridge — UCSF MEDICAL CENTER
Current $-292M → Target $-172M (+$120.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-291.9M
Current EBITDA
$-171.8M
Target EBITDA
+$120.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$27.2M
Payer Mix Optimization
$65.2M
Cost to Collect Reduction
$21.7M
Clean Claim Improvement
$16.3M
Volume & Rate Growth
$108.7M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-292M to $-172M. The highest-impact lever is Volume & Rate Growth at $43.5M probability-weighted.
IC talking point: "We see $120M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $1322M in equity value creation."